Yingchang Mi
YOU?
Author Swipe
View article: Progression significance for low‐level aberrant B‐lymphoblasts in chronic myeloid leukaemia patients
Progression significance for low‐level aberrant B‐lymphoblasts in chronic myeloid leukaemia patients Open
View article: Correction: Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial
Correction: Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial Open
View article: Clinical characteristics and efficacy of short-course antibiotic therapy for <i>Staphylococcus aureus</i> bacteremia in hematological patients
Clinical characteristics and efficacy of short-course antibiotic therapy for <i>Staphylococcus aureus</i> bacteremia in hematological patients Open
To explore the clinical characteristics and outcomes of Staphylococcus aureus bacteremia (SAB) in patients with hematological diseases and evaluate the efficacy of short-course antibiotic therapy for uncomplicated SAB in this group. We per…
View article: Effects of Legume–Grass Mixture Combinations and Planting Ratios on Forage Productivity and Nutritional Quality in Typical Sand-Fixing Vegetation Areas of the Mu Us Sandy Land
Effects of Legume–Grass Mixture Combinations and Planting Ratios on Forage Productivity and Nutritional Quality in Typical Sand-Fixing Vegetation Areas of the Mu Us Sandy Land Open
Monoculture and legume–grass mixed cropping are the two most common planting methods, with mixed cropping generally demonstrating higher hay yield and superior nutritional quality compared to monoculture. However, research on legume–grass …
View article: Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia
Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia Open
B‐cell acute lymphoblastic leukemia (B‐ALL) is a highly heterogeneous disease with a challenging prognosis, particularly in adult patients. We enrolled 88 adult B‐ALL patients with transcriptomic and mutation profiles for classification sy…
View article: Dynamin2 mutations in newly diagnosed acute myeloid leukemia: clinical characteristics, and prognostic significance
Dynamin2 mutations in newly diagnosed acute myeloid leukemia: clinical characteristics, and prognostic significance Open
Acute myeloid leukemia (AML) is a highly heterogeneous myeloid malignancy which can be classified by genetic aberrations. To evaluate the impact of the dynamin 2 mutation in AML, we systematically assessed the characteristics and prognosti…
View article: Classification of acute myeloid leukemia based on multi‐omics and prognosis prediction value
Classification of acute myeloid leukemia based on multi‐omics and prognosis prediction value Open
Acute myeloid leukemia (AML) is a heterogeneous cancer, making outcomes prediction challenging. Several predictive and prognostic models are used but have considerable inaccuracy at individual level. We tried to increase prediction accurac…
View article: [Analysis of risk factors for early death in hyperleukocytic acute leukemia].
[Analysis of risk factors for early death in hyperleukocytic acute leukemia]. Open
Objective: This study analyzed the clinical characteristics and early mortality risk factors in patients with hyperleukocytic acute leukemia (HAL) to provide a basis for predicting early prognosis. Methods: Data were retrospe…
View article: A Machine Learning–Guided Clinical Decision Support System for Early Antibiotic Selection in Pseudomonas Aeruginosa Bloodstream Infections Among Onco-Hematology Patients: A Multicenter Study
A Machine Learning–Guided Clinical Decision Support System for Early Antibiotic Selection in Pseudomonas Aeruginosa Bloodstream Infections Among Onco-Hematology Patients: A Multicenter Study Open
View article: Association between CDSS score and 30-day mortality in non-APL acute leukemia patients with intracranial hemorrhage: A cohort study
Association between CDSS score and 30-day mortality in non-APL acute leukemia patients with intracranial hemorrhage: A cohort study Open
Objectives The aim of this study was to investigate the correlation between CDSS (Chinese DIC Scoring System) score and 30-day mortality in patients with intracranial hemorrhage (ICH) with nonacute promyelocytic leukemia (APL) acute leukem…
View article: Venetoclax combined with three-day multi-frequency decitabine (DEC3-VEN) in elder or intensive chemotherapy ineligible patients with newly diagnosed acute myeloid leukemia
Venetoclax combined with three-day multi-frequency decitabine (DEC3-VEN) in elder or intensive chemotherapy ineligible patients with newly diagnosed acute myeloid leukemia Open
View article: Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial
Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial Open
Previous research has demonstrated that the combination of Venetoclax (Ven) and intensive chemotherapy (IC) enhances the complete response (CR) and minimal residual disease (MRD) negative rate in patients with de novo Acute Myeloid Leukemi…
View article: Strong Homology Between Colonizing and Bloodstream Carbapenem-Resistant Acinetobacter Spp.: Implications for Empiric Antibiotic Therapy in Hematological Patients
Strong Homology Between Colonizing and Bloodstream Carbapenem-Resistant Acinetobacter Spp.: Implications for Empiric Antibiotic Therapy in Hematological Patients Open
Strict infection control measures are needed to manage Acinetobacter spp. colonisation in hematological patients. Appropriate empirical therapy can be administered for suspected CRA BSI based on the antimicrobial minimum inhibitory …
View article: [Venetoclax combined with dose-reduced HAD as induction treatment for patients with de-novo acute myeloid leukemia].
[Venetoclax combined with dose-reduced HAD as induction treatment for patients with de-novo acute myeloid leukemia]. Open
The efficacy and safety of venetoclax combined with reduced dose HAD regimen in the treatment of newly diagnosed acute myeloid leukemia (AML) was investigated. From May 2022 to January 2023, a total of 25 patients with newly diagnosed AML …
View article: The RTK–RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)/FUS::ERG
The RTK–RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)/FUS::ERG Open
Acute myeloid leukemia (AML) with t(16;21)(p11;q22)/ FUS::ERG is a rare AML subtype associated with poor prognosis. However, its clinical and molecular features remain poorly defined. We determined the clinicopathological, genomic, and tra…
View article: CACA guidelines for holistic integrative management of adult acute myeloid leukemia
CACA guidelines for holistic integrative management of adult acute myeloid leukemia Open
The CACA Guidelines was summarized by Hematology Oncology Committee of China Anti- Cancer Association. This portion of the CACA Guidelines for adult acute myeloid leukemia (AML) not only focuses on diagnosis, the treatment options for youn…
View article: Treatment Patterns and FLT3 Mutation Testing Among Patients with Acute Myeloid Leukemia in China: A Retrospective Observational Study
Treatment Patterns and FLT3 Mutation Testing Among Patients with Acute Myeloid Leukemia in China: A Retrospective Observational Study Open
Study findings showed that there was a lack of routine testing for FLT3 mutations at first diagnosis of R/R AML, and initial treatment decisions did not differ by FLT3 mutation status. Given the clinical burden of FLT3…
View article: A pediatric-inspired regimen for adolescent and adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: a prospective study from China
A pediatric-inspired regimen for adolescent and adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: a prospective study from China Open
Several international centers have used and reported on pediatric-inspired regimens to treat adolescent and adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia (Ph– ALL). However, there is a lack of prospectiv…
View article: Multi-Omics Classification System Reveals Biological Differences of Acute Myeloid Leukemia and Clinical Implications
Multi-Omics Classification System Reveals Biological Differences of Acute Myeloid Leukemia and Clinical Implications Open
View article: Association between Serum Lactate Dehydrogenase Level and 30-day Mortality in Patients with Intracranial Hemorrhage with Acute Leukemia in the Induction Phase: A Cohort Study
Association between Serum Lactate Dehydrogenase Level and 30-day Mortality in Patients with Intracranial Hemorrhage with Acute Leukemia in the Induction Phase: A Cohort Study Open
Objectives This study aimed to identify the association between lactate dehydrogenase (LDH) levels and 30-day mortality in patients with intracranial hemorrhage (ICH) with acute leukemia during the induction phase. Methods Th…
View article: Acinetobacter spp. bloodstream infection in hematological patients: a 10-year single-center study
Acinetobacter spp. bloodstream infection in hematological patients: a 10-year single-center study Open
View article: Is Short-Course Antibiotic Therapy Suitable for <i>Pseudomonas aeruginosa</i> Bloodstream Infections in Onco-hematology Patients With Febrile Neutropenia? Results of a Multi-institutional Analysis
Is Short-Course Antibiotic Therapy Suitable for <i>Pseudomonas aeruginosa</i> Bloodstream Infections in Onco-hematology Patients With Febrile Neutropenia? Results of a Multi-institutional Analysis Open
Background Several studies have suggested that short-course antibiotic therapy was effective in Pseudomonas aeruginosa (PA) bloodstream infections (BSI) in immunocompetent patients. But similar studies in patients with hematological malign…
View article: BCR-ABL1 Transcript and Philadelphia Negative T-Cell Lymphoblastic Lymphoma: A Case Report and Literature Review
BCR-ABL1 Transcript and Philadelphia Negative T-Cell Lymphoblastic Lymphoma: A Case Report and Literature Review Open
Background: Lymphoblastic lymphoma (LBL) is a malignant tumor, with most cases derived from T cells and less than 20% arising from B cells. T-LBL originates from immature T cell precursors or lymphoblasts. It is mainly found in the lymph n…
View article: Venetoclax combined with daunorubicin and cytarabine (2 + 6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial
Venetoclax combined with daunorubicin and cytarabine (2 + 6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial Open
View article: Data from A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms
Data from A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms Open
Although the concept of “myeloid neoplasm continuum” has long been proposed, few comparative genomics studies directly tested this hypothesis. Here we report a multi-modal data analysis of 730 consecutive newly diagnosed patients with prim…
View article: Table S1 from A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms
Table S1 from A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms Open
Table S1. Clinicopathologic characteristics of the 730 myeloid neoplasm patients in THAMP.
View article: Table S7 from A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms
Table S7 from A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms Open
Table S7. Prevalence of chromosomal abnormalities in THAMP.
View article: Table S4 from A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms
Table S4 from A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms Open
Table S4. Experimental validation of next-generation sequencing variant calls by Sanger sequencing.
View article: Table S6 from A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms
Table S6 from A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms Open
Table S6. Gene mutation rates in THAMP and comparisons with AACR GENIE 10.0-public.
View article: Table S3 from A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms
Table S3 from A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms Open
Table S3. 171 sequenced genes in THAMP.